Stability of exosomes in the postmortem serum and preliminary study on exosomal miRNA expression profiling in serum from myocardial infarction cadavers
- PMID: 36416963
- DOI: 10.1007/s00414-022-02913-y
Stability of exosomes in the postmortem serum and preliminary study on exosomal miRNA expression profiling in serum from myocardial infarction cadavers
Abstract
Exosome-encapsulated miRNAs could potentially be sensitive biomarkers of human diseases. Since a lipid bilayer membrane surrounds exosomes, the exosomal miRNA may stably exist in body fluids with diseases as well as biological fluids. Therefore, exosomal miRNA may be helpful for autopsy diagnosis. Assuming cadaver blood would be most useful, we initially examined serum exosome stability with regard to storage temperatures and periods. Characteristic analyses of the exosome revealed that exosomes and the content, miRNA, were stably preserved until at least three days when stored at below 20 °C. Subsequently, exosomal miRNA expression profiling was performed on the serum of acute myocardial infarction (AMI, 4 cases) autopsy bodies and on hemorrhagic shock bodies used as the control (CT, 3 cases). Results showed that significant twofold up- and downregulations of expression of 18 and 16 miRNAs were detectable in AMI as compared to the CT, respectively. miR-126-3p, which has been reported to be increased in serum of AMI patients and a mouse model, was one of the significantly upregulated miRNAs. Furthermore, dysregulation of exosomal miRNAs, such as miR-145-5p, miR-143-3p, and miR-222-3p, which are involved in cardioprotection, may be associated with AMI pathogenesis. These findings provide a novel perspective on the potential role of exosomal miRNA in determining the cause of death.
Keywords: Cadaver; Exosome; MicroRNA array analysis; Myocardial infarction; Stability of serum exosome.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Potential liquid biopsy markers of exosomal microRNAs in renal interstitial fibrosis blood and urine.Indian J Pathol Microbiol. 2025 Apr 1;68(2):279-286. doi: 10.4103/ijpm.ijpm_265_24. Epub 2024 Oct 17. Indian J Pathol Microbiol. 2025. PMID: 39787458
-
Comprehensive profiling of serum microRNAs in normal and non-alcoholic fatty liver disease (NAFLD) patients.Sci Rep. 2025 Jan 30;15(1):3766. doi: 10.1038/s41598-025-87791-1. Sci Rep. 2025. PMID: 39885249 Free PMC article.
-
Serum exosomal microRNA profiling reveals a down-regulation of hsa-miR-124-3p in patients with severe acne.Front Immunol. 2025 Jun 23;16:1554811. doi: 10.3389/fimmu.2025.1554811. eCollection 2025. Front Immunol. 2025. PMID: 40625748 Free PMC article.
-
Role of exosomal miRNA in chemotherapy resistance of Colorectal cancer: A systematic review.Chem Biol Drug Des. 2023 May;101(5):1096-1112. doi: 10.1111/cbdd.13947. Epub 2021 Oct 6. Chem Biol Drug Des. 2023. PMID: 34480511
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
Cited by
-
The Role of miRNA Expression Profile in Sudden Cardiac Death Cases.Genes (Basel). 2023 Oct 17;14(10):1954. doi: 10.3390/genes14101954. Genes (Basel). 2023. PMID: 37895303 Free PMC article. Review.
-
Emerging role of exosomes in cancer therapy: progress and challenges.Mol Cancer. 2025 Jan 13;24(1):13. doi: 10.1186/s12943-024-02215-4. Mol Cancer. 2025. PMID: 39806451 Free PMC article. Review.
-
Exosomes in Cardiovascular Disease: From Mechanism to Therapeutic Target.Metabolites. 2023 Mar 27;13(4):479. doi: 10.3390/metabo13040479. Metabolites. 2023. PMID: 37110138 Free PMC article. Review.
-
Global Research Trends on Exosome in Cardiovascular Diseases: A Bibliometric-Based Visual Analysis.Vasc Health Risk Manag. 2024 Aug 22;20:377-402. doi: 10.2147/VHRM.S473520. eCollection 2024. Vasc Health Risk Manag. 2024. PMID: 39188326 Free PMC article. Review.
-
Advancements in extracellular vesicles biomanufacturing: a comprehensive overview of large-scale production and clinical research.Front Bioeng Biotechnol. 2025 Feb 19;13:1487627. doi: 10.3389/fbioe.2025.1487627. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40046812 Free PMC article. Review.
References
-
- Hessvik NP, Llorente A (2018) Current knowledge on exosome biogenesis and release. Cell Mol Life Sci 75:193–208. https://doi.org/10.1007/s00018-017-2595-9 - DOI - PubMed
-
- Akers JC, Ramakrishnan V, Yang I, Hua W, Mao Y, Carter BS, Chen CC (2016) Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid. Cancer Biomark 17:125–132. https://doi.org/10.3233/CBM-160609 - DOI - PubMed - PMC
-
- Iaconetti C, Sorrentino S, De Rosa S, Indolfi C (2016) Exosomal miRNAs in heart disease. Physiol (Bethesda) 31:16–24. https://doi.org/10.1152/physiol.00029.2015 - DOI
-
- Barile L, Moccetti T, Marban E, Vassalli G (2017) Roles of exosomes in cardioprotection. Eur Heart J 38:1372–1379. https://doi.org/10.1093/eurheartj/ehw304 - DOI - PubMed
-
- Kinoshita T, Yip KW, Spence T, Liu FF (2017) MicroRNAs in extracellular vesicles: potential cancer biomarkers. J Hum Genet 62:67–74. https://doi.org/10.1038/jhg.2016.87 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical